Skip to main content
Clinical Trials/ACTRN12605000481673
ACTRN12605000481673
Completed
Phase 2

A double-blind randomised placebo controlled study to evaluate the effects of different doses of testosterone from a Testosterone Metered-Dose Transdermal Spray (MDTS) on sexual function in premenopausal women with low libido

FemPharm Pty Ltd and/or Acrux DDS Pty Ltd0 sites200 target enrollmentSeptember 23, 2005

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
ow libido in post menopausal women suffering from low serum testosterone
Sponsor
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd
Enrollment
200
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 23, 2005
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd

Eligibility Criteria

Inclusion Criteria

  • Postmenopausal women suffering from low libido with low serum testosterone who are otherwise healthy.

Exclusion Criteria

  • No exclusion criteria

Outcomes

Primary Outcomes

Not specified

Similar Trials